id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-282409-gnphco0f	Ozaras, Resat	Coinfections among COVID-19 patients: A Need for Combination Therapy?	2020-08-18		.txt	text/plain	649	42	47	We have recently reported 6 COVID-19 patients coinfected with influenza and reviewed 28 previously reported cases 2 . A review of 14 studies reporting viral coinfecting respiratory pathogens estimated that 3% of hospitalized COVID-19 patients were also coinfected with another respiratory virus; respiratory syncytial virus (16.9% of detections) being the most prevalent one, followed by influenza A (15.5%) 3 . [2] [3] [4] A study from Wuhan, China reported 93 COVID-19 patients, 44 (47.3%) of whom were coinfected with influenza 2 . Therefore, neuraminidase inhibitors, oseltamivir or zanamivir, should be initiated rapidly when influenza co-infection is considered among COVID-19 patients. Although influenza is decreasing during this pandemic because of the measures, clinicians should keep alert COVID-19 patients with influenza coinfection. Combination therapy (adding oseltamivir) should be considered in COVID-19 patients with CT findings suggesting influenza coinfection and/or when there is local circulation of influenza. Influenza and COVID-19 Co-infection: Report of 6 cases and review of the Literature	./cache/cord-282409-gnphco0f.txt	./txt/cord-282409-gnphco0f.txt